SEC Form 4 · accession 0001472343-15-000021
Roka BioScience, Inc. · ROKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Beth Duseau Mary
Officer — SVP, Chief Commercial Officer
Period of report
Feb 4, 2015
Accepted (ET)
Feb 5, 2015 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472343
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.99 | Feb 4, 2015 | A | 104,500 | A | — | Feb 3, 2025 | Common stock, par value $0.001 per share | 104,500 | 104,500 | D |
Explanation of responses
- F1Such stock options vest 25% on the first anniversary and in 1/36th increments on a monthly basis beginning one month after the first anniversary. The stock options have a term of ten years.